Phase II study of epirubicin in combination with weekly docetaxel for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy (Q46077906)
Jump to navigation
Jump to search
scientific article published in April 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of epirubicin in combination with weekly docetaxel for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy |
scientific article published in April 2009 |
Statements
1 reference
Phase II study of epirubicin in combination with weekly docetaxel for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy (English)
1 reference
Chih-Ming Lin
1 reference
Chih-Hung Chen
1 reference
John W C Chang
1 reference
Thomas C Y Tsao
1 reference
1 April 2009
1 reference
32
1 reference
2
1 reference
169-173
1 reference